- Unlock efficiencies across your operations to drastically reduce cost to serve
- Provide unique experiences to customers, no matter how they choose to contact you
- Business Design + Technical Design = Value. KPMG are uniquely positioned to connect the dots between business and technology to increase time to value
Moderator: Verity Charlesworth, Partner, KPMG
For emerging biotechs and biopharmas, the path from early-phase trials to global development is filled with operational and strategic risk. Increasing protocol complexity, fragmented vendor landscapes, and varying regulatory expectations add layers of uncertainty. In this talk, Adam Marsh will outline key inflection points where risk can be proactively mitigated, from study design through execution and scale-up. Attendees will leave with a clearer framework for reducing execution risk while enabling faster, more confident decision-making.
Chairperson: Adil Bundeally, Transformation Director, Risk Advisor & Interim Executive, Lloyds (Former)
Chairperson: Ian Woodhouse, Strategy Advisor, Multrees Investor Services